Literature DB >> 29443198

The US Food and Drug Administration, neurologists, and drug development and regulation.

Gerald J Dal Pan1.   

Abstract

The US Food and Drug Administration (FDA) plays a vital role in the regulation of human drugs and therapeutic biologics. Most physicians, while aware of the broad reach of the FDA, are unaware of what the agency actually does and how it does it. Practicing neurologists should be aware of the role neurologists can play in drug development, the informational resources that the FDA provides to practitioners, and the process of submitting reports of suspected adverse drug reactions to the FDA.

Entities:  

Year:  2015        PMID: 29443198      PMCID: PMC5764476          DOI: 10.1212/CPJ.0000000000000153

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  6 in total

Review 1.  Monitoring the safety of medicines used off-label.

Authors:  G J Dal Pan
Journal:  Clin Pharmacol Ther       Date:  2012-05       Impact factor: 6.875

2.  Dopamine agonists and the risk of cardiac-valve regurgitation.

Authors:  René Schade; Frank Andersohn; Samy Suissa; Wilhelm Haverkamp; Edeltraut Garbe
Journal:  N Engl J Med       Date:  2007-01-04       Impact factor: 91.245

3.  Seizure activity and off-label use of tiagabine.

Authors:  Charlene M Flowers; Judith A Racoosin; Cindy Kortepeter
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

4.  Postmarketing adverse drug reactions: A duty to report?

Authors:  Eran Klein; Dennis Bourdette
Journal:  Neurol Clin Pract       Date:  2013-08

5.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Authors:  David J Graham; Judy A Staffa; Deborah Shatin; Susan E Andrade; Stephanie D Schech; Lois La Grenade; Jerry H Gurwitz; K Arnold Chan; Michael J Goodman; Richard Platt
Journal:  JAMA       Date:  2004-11-22       Impact factor: 56.272

6.  Requirements on content and format of labeling for human prescription drug and biological products. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2006-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.